Source: BioPortfolio

Dimension Therapeutics: Dimension Therapeutics Inc DMTX Financial and Strategic SWOT Analysis Review Report Updated 13092017 Prices from USD $125

Dimension Therapeutics Inc DMTX Financial and Strategic SWOT Analysis Review provides you an indepth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased vi...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
Annalisa Jenkins's photo - CEO of Dimension Therapeutics

CEO

Annalisa Jenkins

CEO Approval Rating

79/100

Read more